Related Experiment Video

Updated: Jul 19, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients?

Antje Neubert1, Harald Dormann, Jutta Weiss

  • 1Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.

European Journal of Clinical Pharmacology
|October 6, 2006
PubMed

Insights

A computerized monitoring system (CMS) for adverse drug reactions (ADRs) showed high sensitivity but low specificity in a pediatric ward. While it detected some ADRs missed by physicians, its low specificity limits daily clinical use for ADR detection in children.

Area of Science:

  • Pharmacoepidemiology
  • Clinical Informatics
  • Pediatric Pharmacology

Background:

  • Adverse drug reactions (ADRs) are a significant concern in pediatric healthcare.
  • Effective detection of ADRs is crucial for patient safety and improved treatment outcomes.
  • Computerized monitoring systems (CMS) offer potential for automated ADR detection.

Purpose of the Study:

  • To evaluate a CMS utilizing laboratory test results for detecting ADRs in a pediatric ward.
  • To compare the ADR detection capabilities of CMS with traditional physician-based reporting.

Main Methods:

  • A 6-month prospective pharmacoepidemiological survey was conducted on a pediatric isolation ward.
  • ADRs were identified through intensive chart review and spontaneous physician reporting.
  • A CMS generated automatic laboratory signals to identify potential ADRs, classified using WHO-ART system organ classes.

Main Results:

  • A total of 73 ADRs were identified; the CMS alerted to 42.4% and physicians solely identified 31.5%.
  • The overall ADR detection rate, combining both methods, reached 74%.
  • The CMS demonstrated high sensitivity (90.3%) but low specificity (19.6%) in alerting to ADRs.

Conclusions:

  • The CMS detected different types of mild adverse events compared to physician observations.
  • While sensitive, the CMS's low specificity makes it currently unacceptable for routine physician use in daily practice.
  • Intensified surveillance remains the optimal method for detecting clinically important ADRs in pediatric patients.
Abstract

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...